AU750792B2 - 76 kDa, 32 kDa, and 50 kDa helicobacter polypeptides and corresponding polynucleotide molecules - Google Patents

76 kDa, 32 kDa, and 50 kDa helicobacter polypeptides and corresponding polynucleotide molecules Download PDF

Info

Publication number
AU750792B2
AU750792B2 AU68757/98A AU6875798A AU750792B2 AU 750792 B2 AU750792 B2 AU 750792B2 AU 68757/98 A AU68757/98 A AU 68757/98A AU 6875798 A AU6875798 A AU 6875798A AU 750792 B2 AU750792 B2 AU 750792B2
Authority
AU
Australia
Prior art keywords
asn
leu
ser
ala
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU68757/98A
Other languages
English (en)
Other versions
AU6875798A (en
Inventor
Amal Al-Garawi
Harold Kleanthous
Ling Lissolo
Charles Miller
Jean-Francois Tomb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MERIEUX ORAVAX
Human Genome Sciences Inc
Original Assignee
MERIEUX ORAVAX
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/834,666 external-priority patent/US20020044949A1/en
Priority claimed from US08/831,310 external-priority patent/US20020026035A1/en
Application filed by MERIEUX ORAVAX, Human Genome Sciences Inc filed Critical MERIEUX ORAVAX
Publication of AU6875798A publication Critical patent/AU6875798A/en
Application granted granted Critical
Publication of AU750792B2 publication Critical patent/AU750792B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU68757/98A 1997-04-01 1998-03-31 76 kDa, 32 kDa, and 50 kDa helicobacter polypeptides and corresponding polynucleotide molecules Ceased AU750792B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/834,666 US20020044949A1 (en) 1997-04-01 1997-04-01 76 kda helicobacter polypeptides and corresponding polynucleotide molecules
US08/834666 1997-04-01
US08/831310 1997-04-01
US08/831,310 US20020026035A1 (en) 1997-04-01 1997-04-01 Helicobacter ghpo 1360 and ghpo 750 polypeptides and corresponding polynucleotide molecules
PCT/US1998/006421 WO1998043479A1 (fr) 1997-04-01 1998-03-31 POLYPEPTIDES D'HELICOBACTER DE 76 kDa, 32 kDa ET 50 kDa ET MOLECULES DE POLYNUCLEOTIDES CORRESPONDANTES

Publications (2)

Publication Number Publication Date
AU6875798A AU6875798A (en) 1998-10-22
AU750792B2 true AU750792B2 (en) 2002-07-25

Family

ID=27125431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68757/98A Ceased AU750792B2 (en) 1997-04-01 1998-03-31 76 kDa, 32 kDa, and 50 kDa helicobacter polypeptides and corresponding polynucleotide molecules

Country Status (5)

Country Link
EP (1) EP0980204A4 (fr)
JP (1) JP2001523954A (fr)
AU (1) AU750792B2 (fr)
CA (1) CA2286893A1 (fr)
WO (1) WO1998043479A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4718999A (en) * 1998-06-26 2000-01-17 American Cyanamid Company Novel antigens of (helicobacter pylori)
TWI237695B (en) * 1999-12-14 2005-08-11 Joy Biomedical Corp Helicobacter pylori antigens in blood
WO2002066502A1 (fr) * 2001-02-21 2002-08-29 Boren Thomas Adhesine de liaison de l'acide sialique d'helicobacter pylori, saba et gene de saba
WO2003059380A2 (fr) * 2002-01-15 2003-07-24 Bio Life Science Forschungs Und Entwicklungsges M.B.H. Vaccination orale
DE50210696D1 (de) * 2002-01-15 2007-09-27 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh Orale Vakzinierung mit nackten Tumor-Antigen-Mimotopen
JP5250812B2 (ja) * 2006-04-27 2013-07-31 国立大学法人富山大学 ヘリコバクター・ピロリ菌由来の新規抗原、抗原組成物およびピロリ菌抗体の検出方法。

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258729A (en) * 1992-08-06 1993-11-02 Eaton Corporation Case circuit breaker having improved attachment means for accessory devices and accessory devices therefor
WO1997011182A1 (fr) * 1995-09-22 1997-03-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Berlin Nouvelle adhesine obtenue a partir de helicobacter pylori

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3887353T2 (de) * 1987-10-12 1994-05-05 Capability Services Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
US5258178A (en) * 1990-07-30 1993-11-02 Abbott Laboratories Method and product for the treatment of gastric disease
US5116821A (en) * 1990-11-20 1992-05-26 The Procter & Gamble Company Sulfated glyceroglucolipids as inhibitors of bacterial adherence
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
WO1995008332A1 (fr) * 1993-09-20 1995-03-30 The Procter & Gamble Company Utilisation de phosphates de triclosan dans le traitement de troubles gastrointestinaux dus a l'infection a heliobacter
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
US5563039A (en) * 1995-03-31 1996-10-08 Tularik, Inc. TNF receptor-associated intracellular signaling proteins and methods of use
SK165197A3 (en) * 1995-06-07 1999-01-11 Astra Ab Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
FR2739623B1 (fr) * 1995-10-04 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle proteine membranaire p76 d'helicobacter pylori

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258729A (en) * 1992-08-06 1993-11-02 Eaton Corporation Case circuit breaker having improved attachment means for accessory devices and accessory devices therefor
WO1997011182A1 (fr) * 1995-09-22 1997-03-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Berlin Nouvelle adhesine obtenue a partir de helicobacter pylori

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
INFECTION AND IMMUNITY 61(6) 2732-2736 1993 *

Also Published As

Publication number Publication date
AU6875798A (en) 1998-10-22
EP0980204A4 (fr) 2005-06-15
CA2286893A1 (fr) 1998-10-08
EP0980204A1 (fr) 2000-02-23
WO1998043479A1 (fr) 1998-10-08
JP2001523954A (ja) 2001-11-27

Similar Documents

Publication Publication Date Title
JP4271952B2 (ja) ワクチンおよび診断に有用なHelicobacterpyloriタンパク質
AU780444B2 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU784193B2 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
JP2006055168A (ja) ワクチンおよび診断に有用なHelicobacterpyloriタンパク質
WO2002018595A9 (fr) Polypeptides de moraxella et fragments d'adn correspondants et utilisations
US7629327B2 (en) Chlamydia 60 Kda CRMP antigens and vaccine uses
JP2001527393A (ja) ヘリコバクターゲノム中の新規ヘリコバクターポリペプチドをコードするポリヌクレオチドの同定
JP2000125889A (ja) アクチノバチルス・プレウロニウモニアからのタンパク質
CZ297698A3 (cs) Sekvence nukleové kyseliny a aminokyselinové sekvence vztahující se k Helicobacter pylori a její vakcinační kompozice
AU750792B2 (en) 76 kDa, 32 kDa, and 50 kDa helicobacter polypeptides and corresponding polynucleotide molecules
US20030158396A1 (en) Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
AU735391B2 (en) Helicobacter polypeptides and corresponding polynucleotide molecules
US20030225017A1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US20030124141A1 (en) Helicobacter polypeptides and corresponding polynucleotide molecules
US20080019994A1 (en) Immunization Against Chlamydia Infection
US20020115078A1 (en) Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US20020044949A1 (en) 76 kda helicobacter polypeptides and corresponding polynucleotide molecules
US20030023066A1 (en) Helicobacter polypeptides and corresponding polynucleotide molecules
US20020026035A1 (en) Helicobacter ghpo 1360 and ghpo 750 polypeptides and corresponding polynucleotide molecules
US20020160456A1 (en) Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US6296855B1 (en) 17-KDA Brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
US20030069404A1 (en) Helicobacter antigens and corresponding DNA fragments
JP2001503637A (ja) ヘリコバクターポリペプチドおよび対応するポリヌクレオチド分子
EP1535928B1 (fr) Vaccin comprenant Omp85 protéines de Neisseria gonorhoeae et Neisseria meningitidis
MXPA01006663A (es) Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)